COMPLETE GENOMICS INC·4

Nov 16, 2:09 PM ET

CASKEY C THOMAS 4

4 · COMPLETE GENOMICS INC · Filed Nov 16, 2010

Insider Transaction Report

Form 4
Period: 2010-11-16
Transactions
  • Conversion

    Series D Preferred Stock

    2010-11-163,3070 total
    Common Stock (3,307 underlying)
  • Conversion

    Common Stock, par value $0.001

    2010-11-16+1,8445,151 total
  • Conversion

    Series E Preferred Stock

    2010-11-161,8440 total
    Common Stock (1,844 underlying)
  • Conversion

    Common Stock, par value $0.001

    2010-11-16+3,3073,307 total
Footnotes (3)
  • [F1]Each share of Series D and Series E Preferred Stock automatically converted into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering.
  • [F2]The securities are immediately convertible.
  • [F3]The expiration date is not relevant to the conversion of these securities.

Documents

1 file
  • 4
    rrd291102.xmlPrimary

    FORM 4